National Australia Bank chairman Phil Chronican will challenge companies to take more aggressive risks and emulate the success of local biotech and tech champions such as CSL, Cochlear and Atlassian to boost growth in a speech on Monday.
He is one of several business leaders urging companies to reinvest in their operations and reinvent their companies more aggressively or risk squandering the advantages handed to them by Australia’s adroit management of the COVID-19 pandemic.
Loading...
Lucas Baird is a journalist based in The Australian Financial Review's Sydney office. Connect with Lucas on Twitter. Email Lucas at lucas.baird@afr.com
Sally Patten edits BOSS, and writes about workplace issues. She was the financial services editor and personal finance editor of the AFR, The Age and the Sydney Morning Herald. She edited business news for The Times of London. Connect with Sally on Twitter. Email Sally at spatten@afr.com
Natasha Gillezeau is a journalist for The Australian Financial Review based in the Sydney office. Connect with Natasha on Twitter.
